title: A Randomized Trial Testing US Food and Drug Administration "Breakthrough" Language.
authors.affiliation: Department of Engineering and Public Policy, Carnegie Mellon University, Pittsburgh, Pennsylvania.
authors.forename: Tamar
authors.initials: T
authors.lastname: Krishnamurti
authors.affiliation: The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire.
authors.forename: Steven
authors.initials: S
authors.lastname: Woloshin
authors.affiliation: The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire.
authors.forename: Lisa M
authors.initials: LM
authors.lastname: Schwartz
authors.affiliation: Department of Engineering and Public Policy, Carnegie Mellon University, Pittsburgh, Pennsylvania3Department of Social and Decision Sciences, Carnegie Mellon University, Pittsburgh, Pennsylvania.
authors.forename: Baruch
authors.initials: B
authors.lastname: Fischhoff
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000592:standards*; D017277:Drug Approval / Q000379:methods*; D005260:Female; D064368:Healthy Volunteers; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D011795:Surveys and Questionnaires; D009626:Terminology as Topic; D035703:Therapies, Investigational / Q000379:methods / Q000592:standards; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000970:Antineoplastic Agents